The in vitro effects of cigarette smoke on fatty acid metabolism are partially counteracted by simvastatin

Prostaglandins, Leukotrienes, and Essential Fatty Acids
Patrizia RiséClaudio Galli

Abstract

Statins enhance the synthesis of long-chain polyunsaturated fatty acids (LC-PUFAs) from their precursors both in vitro and in vivo. In particular, an increased conversion of linoleic acid (LA) and of alpha-linolenic acid to their derivatives is observed in cultured cells. On the contrary, cigarette smoke (CS) negatively and dose-dependently affects the LC-PUFA production. To evaluate the effects of CS alone or with simvastatin, on [1-(14)C] LA metabolism in THP-1 cells. CS inhibits LA conversion; after co-incubation, simvastatin nullifies the effects of CS, maintaining LA conversion comparable to controls. However, at the highest CS concentration, simvastatin is unable to counteract the effects of CS. Changes of LA conversion reflect the modulation of desaturase activities by simvastatin and CS. CS decreases PUFA conversion and its effects are modulated by the opposite effect of statins. It can be speculated that statin treatments in smoking patients may provide some beneficial effects on PUFA metabolism in addition to lowering cholesterol levels.

References

Dec 1, 1985·Environmental Health Perspectives·D F Church, W A Pryor
Apr 1, 1993·Journal of the Royal Society of Health·B Halliwell
Aug 15, 1996·American Journal of Epidemiology·J A SimonW S Browner
Sep 27, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·P RiséC Galli
Jan 23, 2003·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Johnathan A NapierOlga Sayanova
Apr 23, 2003·European Journal of Pharmacology·Patrizia RiséClaudio Galli
Jun 10, 2003·Clinical Science·Justin C Mason
Nov 19, 2003·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Ravinder D Reddy, Jeffrey K Yao
Dec 13, 2005·Circulation Research·Yoshiyuki Rikitake, James K Liao
Jan 20, 2007·Journal of Lipid Research·Robert J PawloskyNorman Salem
Dec 1, 2007·Journal of Cardiovascular Pharmacology·Gehan HeebaTadeusz Malinski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Ioannis LabadaridisHelen Michelakakis
The Cochrane Database of Systematic Reviews
K Simmer, S Patole
© 2021 Meta ULC. All rights reserved